Advanced Medical Solutions Group (FRA:AQA) ROCE % : 6.63% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Advanced Medical Solutions Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Advanced Medical Solutions Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 6.63%.

Advanced Medical Solutions Group ROCE % Historical Data

The historical data trend for Advanced Medical Solutions Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group ROCE % Chart

Advanced Medical Solutions Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.83

4.68

10.10

10.59

8.23

Advanced Medical Solutions Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															9.48	10.61	10.79	9.65	6.63

Advanced Medical Solutions Group ROCE % Calculation

Advanced Medical Solutions Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	25.004	/	( ( (323.207 - 26.076)	+	(335.658 - 25.053) )	/ 2 )
	=	25.004	/	( (297.131	+	310.605)	/ 2 )
	=	25.004	/	303.868
	=	8.23 %

Advanced Medical Solutions Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	20.676	/	( ( (339.802 - 26.504)	+	(335.658 - 25.053) )	/ 2 )
	=	20.676	/	( ( 313.298	+	310.605 )	/ 2 )
	=	20.676	/	311.9515
	=	6.63 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Advanced Medical Solutions Group (FRA:AQA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Advanced Medical Solutions Group ROCE % Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Medical Solutions Group (FRA:AQA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (FRA:AQA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

AMS.GB:UK AMS:UK AQA:Germany

Address

Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT

Website

https://www.admedsol.com

U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.

Advanced Medical Solutions Group (FRA:AQA) Headlines

No Headlines